Phase 3 colorectal cancer trial misses survival endpoint
A randomized phase 3 trial designed to compare an investigational combination with standard care for certain patients with advanced colorectal cancer failed to meet its primary endpoint of OS.The KEYFORM-007 trial included 441 patients with previously treated PD-L1-positive, microsatellite stable metastatic colorectal cancer.